Company intelligence / Profile preview

Wuhan Ailite Biotechnology

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan Ailite Biotechnology is a high-tech enterprise based in Wuhan, China, specializing in the research, development, and manufacturing of molecular diagnostic products. The company focuses on providing comprehensive solutions for clinical diagnostics, including automated nucleic acid extraction systems and PCR-based detection kits for infectious diseases and oncology. Their core product portfolio features advanced testing for Human Papillomavirus (HPV), respiratory pathogens, and tuberculosis. Wuhan Ailite Biotechnology serves hospitals, CDC centers, and research institutions, aiming to improve public health through precise and efficient diagnostic technologies.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Diagnostic kitRecombinant proteinAntibody
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Wuhan Ailite Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Ailite Biotechnology.

Explore the full profile